Literature DB >> 7026050

E. coli mutant pleiotropically defective in the export of secreted proteins.

D B Oliver, J Beckwith.   

Abstract

A hybrid beta-galactosidase molecule containing a substantial portion of the amino-terminal sequence of the maltose-binding protein is inserted in the cytoplasmic membrane of E. coli; in this location, the protein has very low enzymatic activity. The strain producing it is, therefore, Lac-. Selection for derivatives of the fusion strain that are able to grow on lactose yields mutants in which the hybrid protein has become cytoplasmic, and thus has higher enzymatic activity. Among such derivatives, we have isolated a temperature-sensitive conditional lethal mutant that accumulates the precursor of the maltose-binding protein in the cytoplasm, and also accumulates precursors of alkaline phosphatase, lambda receptor protein and the ompF gene gene product. A number of periplasmic proteins are, however, properly localized at the nonpermissive temperature. The temperature-sensitive lesion has been genetically mapped to 2.5 min on the E. coli map, within or near a cluster of genes responsible for cell division and septation. The principle behind the genetic selection employed here should be useful in obtaining other secretion mutants to characterize the cell's secretion machinery.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7026050     DOI: 10.1016/0092-8674(81)90184-7

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  224 in total

1.  Green fluorescent protein functions as a reporter for protein localization in Escherichia coli.

Authors:  B J Feilmeier; G Iseminger; D Schroeder; H Webber; G J Phillips
Journal:  J Bacteriol       Date:  2000-07       Impact factor: 3.490

2.  Identification and analysis of bacterial protein secretion inhibitors utilizing a SecA-LacZ reporter fusion system.

Authors:  L E Alksne; P Burgio; W Hu; B Feld; M P Singh; M Tuckman; P J Petersen; P Labthavikul; M McGlynn; L Barbieri; L McDonald; P Bradford; R G Dushin; D Rothstein; S J Projan
Journal:  Antimicrob Agents Chemother       Date:  2000-06       Impact factor: 5.191

3.  Differential dependence of levansucrase and alpha-amylase secretion on SecA (Div) during the exponential phase of growth of Bacillus subtilis.

Authors:  L Leloup; A J Driessen; R Freudl; R Chambert; M F Petit-Glatron
Journal:  J Bacteriol       Date:  1999-03       Impact factor: 3.490

4.  Critical regions of secM that control its translation and secretion and promote secretion-specific secA regulation.

Authors:  Shameema Sarker; Donald Oliver
Journal:  J Bacteriol       Date:  2002-05       Impact factor: 3.490

5.  The YSIRK-G/S motif of staphylococcal protein A and its role in efficiency of signal peptide processing.

Authors:  Taeok Bae; Olaf Schneewind
Journal:  J Bacteriol       Date:  2003-05       Impact factor: 3.490

6.  Yop fusions to tightly folded protein domains and their effects on Yersinia enterocolitica type III secretion.

Authors:  Vincent T Lee; Olaf Schneewind
Journal:  J Bacteriol       Date:  2002-07       Impact factor: 3.490

7.  Molecular cloning of staphylococcal enterotoxin B gene in Escherichia coli and Staphylococcus aureus.

Authors:  D M Ranelli; C L Jones; M B Johns; G J Mussey; S A Khan
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

8.  Ring-like pore structures of SecA: implication for bacterial protein-conducting channels.

Authors:  Hong-Wei Wang; Yong Chen; Hsiuchin Yang; Xianchuan Chen; Ming-Xing Duan; Phang C Tai; Sen-Fang Sui
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-17       Impact factor: 11.205

9.  The use of extragenic suppressors to define genes involved in protein export in Escherichia coli.

Authors:  E R Brickman; D B Oliver; J L Garwin; C Kumamoto; J Beckwith
Journal:  Mol Gen Genet       Date:  1984

10.  Convenient transduction of recA with bacteriophage T4GT7.

Authors:  S Plakidou; K G Moffat; G P Salmond; G Mackinnon
Journal:  J Bacteriol       Date:  1984-09       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.